Flputnam Investment Management Co. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 19.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,315 shares of the exchange traded fund’s stock after selling 4,033 shares during the period. Flputnam Investment Management Co.’s holdings in SPDR S&P Biotech ETF were worth $1,635,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in the company. DHJJ Financial Advisors Ltd. bought a new stake in SPDR S&P Biotech ETF during the second quarter worth $25,000. Capital A Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $26,000. Johnson Financial Group Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $31,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth $32,000. Finally, AlphaCore Capital LLC lifted its position in shares of SPDR S&P Biotech ETF by 6,650.0% during the 2nd quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock worth $45,000 after buying an additional 532 shares during the last quarter.
SPDR S&P Biotech ETF Stock Up 2.0%
NYSEARCA:XBI opened at $125.91 on Tuesday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $126.50. The stock’s 50-day simple moving average is $115.61 and its 200 day simple moving average is $99.12. The firm has a market capitalization of $7.64 billion, a PE ratio of 11.47 and a beta of 0.93.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The Last Gold Bull Market
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
